One of the most exciting advances in cancer treatments in the past decade is the development of T cell immunotherapies, in which a patient's own immune system is trained to recognize and attack ...
The Stanford summary backs up the "rare" label with specific numbers: about one myocarditis case per 140,000 people after a ...
In recent years, the psychedelic compound psilocybin found in magic mushrooms has been widely tested for its antidepressant ...
Why it matters: It's reportedly still one of the best-selling songs of all time in any genre, though chart data from decades ...
Alaska corrections officials have said no foul play was suspected in the January 2024 death of Joshua Keith Zimmerman. His ...
In a new weekly update for pv magazine, OPIS, a Dow Jones company, provides a quick look at the main price trends in the global PV industry.
WTX-124 initial Phase 1b expansion arm data showed 30% overall response rate as a monotherapy in a defined subset of post-ICI ...
P72, a HER2 × CD3 T cell engager, with preclinical studies demonstrating enhanced HER2-high tumor selectivity and a favorable safety profile ABP-102/CT-P72 represents Abpro's ...
C3.ai, Inc. engages in the provision of enterprise artificial intelligence software for digital transformation. It delivers the C3 AI suite for developing, deploying, and operating large-scale AI, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback